Release date: 2026-06-26 17:54:16 Recommended: 21
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long relied on imports of high-quality generic medicines from countries such as China and India. The pharmaceutical and medical device market in Laos is regulated by the Food and Drug Bureau. In recent years, with increased openness and favorable policies, some pharmaceutical companies have chosen to set up factories in Laos, and the countrys pharmaceutical sector has shown certain development momentum. The following are the major pharmaceutical companies currently operating in Laos.
Lucius Pharmaceuticals was established in 2020 and is located at No. 26, Thongmang Village, Xaysettha District, Vientiane, the capital of Laos. The company is a legally approved pharmaceutical manufacturer by the Lao government.
Production scale: Lucius Pharmaceuticals' factory covers an area of approximately 210,000 square meters. The company now produces over 200 generic drug varieties, covering multiple therapeutic areas. As of June 2024, Lucius Pharmaceuticals has obtained marketing approvals for 54 anticancer drugs.
Product portfolio: Lucius Pharmaceuticals focuses on antineoplastic agents as its core product line, having developed generic versions of targeted therapies including sotorasib, osimertinib, cabozantinib, larotrectinib, lorlatinib, and crizotinib. In addition, the company's products also include antihypertensive drugs such as aprocitentan.
Market presence: Lucius Pharmaceuticals has expanded its business to 12 countries, including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Sri Lanka, Turkey, Japan, and China, and has established extensive partnerships.
Lao Alliance Pharmaceutical Group, founded in 2017, is a comprehensive pharmaceutical company integrating R&D, production, and sales. It occupies about 80 mu (approx. 5.3 hectares) and currently employs 243 staff. The company is one of the largest pharmaceutical enterprises in Laos and one of the three OTC drug manufacturers, holding about 27% of the Lao pharmaceutical market. Currently, the group is investing RMB 1.5 billion to build a new plant, with an expected annual output value of RMB 5 billion upon completion, which is poised to become the largest pharmaceutical factory in Southeast Asia.
The National Pharmaceutical Factory No. 2 is a state-owned pharmaceutical enterprise under the direct supervision of the Lao Ministry of Health. Established in the 1970s, it is one of the most comprehensive drug producers in Laos, with over 160 products including infusions, injections, oral tablets, oral capsules, oral syrups, ointments, and more.
In addition, Laos also has other state-owned manufacturers such as the National Pharmaceutical Factory No. 3.
Apart from the above, there are several other pharmaceutical companies in Laos, including ASEAN Food and Drug (Laos) Co., Ltd., Lao-Viet Pharmaceutical Factory, KPN Pharmaceutical Co., Ltd., and Lao Element Pharmaceutical, among others. These enterprises have all obtained official drug marketing approvals, and some of them specialize in the production of generic anticancer drugs.
Overall, the pharmaceutical industry in Laos remains in a developing stage, with a limited number of factories. However, companies like Lucius Pharmaceuticals are gradually expanding both domestic and international markets, driving the industry forward.
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug ···【more】
Recommended:22Release date: 2026-06-26
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended:620Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended:621Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended:761Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended:556Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended:789Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:721Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:673Release date: 2024-07-09
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has f···【more】
Recommended:34Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durv···【more】
Recommended:146Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended:499Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended:454Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended:478Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended:463Release date: 2025-12-08